Balyasny Asset Management LLC Myovant Sciences Ltd. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$24.03 - $27.02 $2.72 Million - $3.05 Million
113,050 New
113,050 $3.05 Million
Q2 2022

Aug 15, 2022
BUY
$7.78 - $14.69 $818,051 - $1.54 Million
105,148 Added 33.66%
417,496 $5.19 Million
Q1 2022

May 16, 2022
BUY
$11.38 - $16.4 $1.25 Million - $1.8 Million
109,777 Added 54.19%
312,348 $4.16 Million
Q4 2021

Feb 14, 2022
BUY
$14.31 - $23.87 $2.9 Million - $4.84 Million
202,571 New
202,571 $3.15 Million

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email